MYC Disrupts the Circadian Clock and Metabolism in Cancer Cells.

[1]  A. McCallion,et al.  Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis. , 2015, The Journal of clinical investigation.

[2]  Charles Y. Lin,et al.  Taming of the beast: shaping Myc-dependent amplification. , 2015, Trends in cell biology.

[3]  Enrico Gratton,et al.  In vivo single-cell detection of metabolic oscillations in stem cells. , 2015, Cell reports.

[4]  J. Takahashi,et al.  Transcriptional program of Kpna2/Importin-α2 regulates cellular differentiation-coupled circadian clock development in mammalian cells , 2014, Proceedings of the National Academy of Sciences.

[5]  H. Lai,et al.  Epigenetic silencing of ARNTL, a circadian gene and potential tumor suppressor in ovarian cancer. , 2014, International journal of oncology.

[6]  L. Zender,et al.  Activation and repression by oncogenic MYC shape tumour-specific gene expression profiles , 2014, Nature.

[7]  Chris Sander,et al.  Emerging landscape of oncogenic signatures across human cancers , 2013, Nature Genetics.

[8]  J. Takahashi,et al.  Usf1, a suppressor of the circadian Clock mutant, reveals the nature of the DNA-binding of the CLOCK:BMAL1 complex in mice , 2013, eLife.

[9]  F. Westermann,et al.  Hox-C9 activates the intrinsic pathway of apoptosis and is associated with spontaneous regression in neuroblastoma , 2013, Cell Death and Disease.

[10]  Steven J. M. Jones,et al.  The genetic landscape of high-risk neuroblastoma , 2013, Nature Genetics.

[11]  Michael Koutsilieris,et al.  Circadian Rhythm Disruption in Cancer Biology , 2012, Molecular medicine.

[12]  J. Bass,et al.  Circadian topology of metabolism , 2012, Nature.

[13]  D. Sabatini,et al.  Cancer cell metabolism: one hallmark, many faces. , 2012, Cancer discovery.

[14]  Logan J Everett,et al.  Rev-erbα and Rev-erbβ coordinately protect the circadian clock and normal metabolic function. , 2012, Genes & development.

[15]  Chi V Dang,et al.  MYC on the Path to Cancer , 2012, Cell.

[16]  Satchidananda Panda,et al.  Regulation of Circadian Behavior and Metabolism by Rev-erbα and Rev-erbβ , 2012, Nature.

[17]  Paolo Sassone-Corsi,et al.  Regulation of metabolism: the circadian clock dictates the time , 2012, Trends in Endocrinology & Metabolism.

[18]  A. Menssen,et al.  The c-MYC oncoprotein, the NAMPT enzyme, the SIRT1-inhibitor DBC1, and the SIRT1 deacetylase form a positive feedback loop , 2011, Proceedings of the National Academy of Sciences.

[19]  Achim Kramer,et al.  Tuning the Mammalian Circadian Clock: Robust Synergy of Two Loops , 2011, PLoS Comput. Biol..

[20]  Ueli Schibler,et al.  Crosstalk between components of circadian and metabolic cycles in mammals. , 2011, Cell metabolism.

[21]  Joseph S. Takahashi,et al.  Circadian Integration of Metabolism and Energetics , 2010, Science.

[22]  Karl Kornacker,et al.  JTK_CYCLE: An Efficient Nonparametric Algorithm for Detecting Rhythmic Components in Genome-Scale Data Sets , 2010, Journal of biological rhythms.

[23]  J. Maris.  Recent advances in neuroblastoma. , 2010, The New England journal of medicine.

[24]  Ritu Jain,et al.  An RNA interference screen identifies metabolic regulators NR1D1 and PBP as novel survival factors for breast cancer cells with the ERBB2 signature. , 2010, Cancer research.

[25]  Jean Clairambault,et al.  Circadian timing in cancer treatments. , 2010, Annual review of pharmacology and toxicology.

[26]  Paolo Sassone-Corsi,et al.  Metabolism and cancer: the circadian clock connection , 2009, Nature Reviews Cancer.

[27]  E. Ballestar,et al.  Epigenetic inactivation of the circadian clock gene BMAL1 in hematologic malignancies. , 2009, Cancer research.

[28]  J. Takahashi,et al.  Circadian Clock Feedback Cycle Through NAMPT-Mediated NAD+ Biosynthesis , 2009, Science.

[29]  Satchidananda Panda,et al.  Network Features of the Mammalian Circadian Clock , 2009, PLoS biology.

[30]  R. Eisenman,et al.  Myc's broad reach. , 2008, Genes & development.

[31]  N. Yaegashi,et al.  Clinicopathological significance of circadian rhythm‐related gene expression levels in patients with epithelial ovarian cancer , 2008, Acta obstetricia et gynecologica Scandinavica.

[32]  M. Hogarty,et al.  N-myc augments death and attenuates protective effects of Bcl-2 in trophically stressed neuroblastoma cells , 2008, Oncogene.

[33]  G. Semenza,et al.  Hypoxia-Inducible Factor 1 and Dysregulated c-Myc Cooperatively Induce Vascular Endothelial Growth Factor and Metabolic Switches Hexokinase 2 and Pyruvate Dehydrogenase Kinase 1 , 2007, Molecular and Cellular Biology.

[34]  Ueli Schibler,et al.  System-Driven and Oscillator-Dependent Circadian Transcription in Mice with a Conditionally Active Liver Clock , 2007, PLoS biology.

[35]  Erin L. McDearmon,et al.  Dissecting the Functions of the Mammalian Clock Protein BMAL1 by Tissue-Specific Rescue in Mice , 2006, Science.

[36]  W. Gerald,et al.  Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number. , 2006, Cancer research.

[37]  Erin E. Carlson,et al.  Targeted profiling: quantitative analysis of 1H NMR metabolomics data. , 2006, Analytical chemistry.

[38]  M. Antoch,et al.  Dual role of the CLOCK/BMAL1 circadian complex in transcriptional regulation , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[39]  Hiroki R Ueda,et al.  Feedback repression is required for mammalian circadian clock function , 2006, Nature Genetics.

[40]  R. Versteeg,et al.  Inhibition of a new differentiation pathway in neuroblastoma by copy number defects of N-myc, Cdc42, and nm23 genes. , 2005, Cancer research.

[41]  Christopher H. Contag,et al.  MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer , 2004, Nature.

[42]  Peng Huang,et al.  The Circadian Gene Period2 Plays an Important Role in Tumor Suppression and DNA Damage Response In Vivo , 2002, Cell.

[43]  Ueli Schibler,et al.  The Orphan Nuclear Receptor REV-ERBα Controls Circadian Transcription within the Positive Limb of the Mammalian Circadian Oscillator , 2002, Cell.

[44]  Steven A. Brown,et al.  Resetting of circadian time in peripheral tissues by glucocorticoid signaling. , 2000, Science.

[45]  F. Alt,et al.  N-myc can functionally replace c-myc in murine development, cellular growth, and differentiation. , 2000, Genes & development.

[46]  J. Hogenesch,et al.  The basic-helix-loop-helix-PAS orphan MOP3 forms transcriptionally active complexes with circadian and hypoxia factors. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[47]  G. Evan,et al.  A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. , 1995, Nucleic acids research.

[48]  R. Xu,et al.  Prognostic relevance of Period1 (Per1) and Period2 (Per2) expression in human gastric cancer. , 2014, International journal of clinical and experimental pathology.

[49]  Jamey D. Young,et al.  Isotopically nonstationary 13C flux analysis of Myc-induced metabolic reprogramming in B-cells. , 2013, Metabolic engineering.